A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease

MeSH terms

• Anemia / chemically induced
• Anemia / drug therapy*
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Darbepoetin alfa
• Dose-Response Relationship, Drug
• Epoetin Alfa
• Erythropoietin / administration & dosage*
• Erythropoietin / analogs & derivatives*
• Erythropoietin / therapeutic use
• Hematinics / therapeutic use
• Humans
• Neoplasms / drug therapy
• Recombinant Proteins